Literature DB >> 11790535

Interactions between MHC molecules and co-receptors of the TCR.

Rolf König1.   

Abstract

Genetic experiments indicate similarity between binding sites on MHC class I (MHCI) for CD8 and on MHCII for CD4, but the crystal structures of CD8/MHCI and CD4/MHCII complexes suggest critical differences between the interfaces in the two complexes. Biophysical analyses using ectodomains of co-receptors and MHC molecules demonstrate extremely fast kinetics and low-affinity interactions. Experiments with soluble multimeric MHC ligands suggest that CD4 and CD8 may differ in the mechanisms by which they promote the formation of ternary TCR/MHC/co-receptor complexes. Co-receptor-influenced duration of TCR signaling controls thymocyte selection. In naïve T cells, CD4/MHCII interactions may promote T-cell survival. Temporal and spatial analysis of TCR and CD4 co-clustering in the immunological synapse suggests that CD4 recruitment is regulated by the half-life of the initial TCR/MHCII complex. Diverse experimental systems have yielded conflicting data that have helped to formulate revised mechanistic models of co-receptor function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11790535     DOI: 10.1016/s0952-7915(01)00300-4

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  25 in total

1.  CD8 kinetically promotes ligand binding to the T-cell antigen receptor.

Authors:  Dmitry M Gakamsky; Immanuel F Luescher; Aladdin Pramanik; Ronen B Kopito; François Lemonnier; Horst Vogel; Rudolf Rigler; Israel Pecht
Journal:  Biophys J       Date:  2005-06-24       Impact factor: 4.033

2.  Memory generation and maintenance of CD8+ T cell function during viral persistence.

Authors:  Stephanie S Cush; Kathleen M Anderson; David H Ravneberg; Janet L Weslow-Schmidt; Emilio Flaño
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

Review 3.  A role for "self" in T-cell activation.

Authors:  Michelle Krogsgaard; Jeremy Juang; Mark M Davis
Journal:  Semin Immunol       Date:  2007-06-04       Impact factor: 11.130

4.  Contribution of T cell receptor affinity to overall avidity for virus-specific CD8+ T cell responses.

Authors:  Katherine Kedzierska; Nicole L La Gruta; Miles P Davenport; Stephen J Turner; Peter C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-01       Impact factor: 11.205

5.  Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoprotein.

Authors:  Nicholas Veomett; Tao Dao; Hong Liu; Jingyi Xiang; Dmitry Pankov; Leonid Dubrovsky; Joseph A Whitten; Sun-Mi Park; Tatyana Korontsvit; Victoria Zakhaleva; Emily Casey; Michael Curcio; Michael G Kharas; Richard J O'Reilly; Cheng Liu; David A Scheinberg
Journal:  Clin Cancer Res       Date:  2014-05-21       Impact factor: 12.531

6.  Feedback control of T-cell receptor activation.

Authors:  Cliburn Chan; Jaroslav Stark; Andrew J T George
Journal:  Proc Biol Sci       Date:  2004-05-07       Impact factor: 5.349

7.  Role of Abl kinase and the Wave2 signaling complex in HIV-1 entry at a post-hemifusion step.

Authors:  Brooke Harmon; Nancy Campbell; Lee Ratner
Journal:  PLoS Pathog       Date:  2010-06-17       Impact factor: 6.823

8.  Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region.

Authors:  Linda Wooldridge; Anna Lissina; Jonathan Vernazza; Emma Gostick; Bruno Laugel; Sarah L Hutchinson; Fareed Mirza; P Rod Dunbar; Jonathan M Boulter; Meir Glick; Vincenzo Cerundolo; Hugo A van den Berg; David A Price; Andrew K Sewell
Journal:  Eur J Immunol       Date:  2007-05       Impact factor: 5.532

9.  The strength of T cell receptor signal controls the polarization of cytotoxic machinery to the immunological synapse.

Authors:  Misty R Jenkins; Andy Tsun; Jane C Stinchcombe; Gillian M Griffiths
Journal:  Immunity       Date:  2009-10-16       Impact factor: 43.474

10.  Anti-CD4-mediated selection of Treg in vitro - in vitro suppression does not predict in vivo capacity to prevent graft rejection.

Authors:  Vanessa Oliveira; Birgit Sawitzki; Stephanie Chapman; Christine Appelt; Inga Gebuhr; Joanna Wieckiewicz; Elaine Long; Kathryn J Wood
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.